{"id":"W4392514676","doi":"10.1038/s42003-024-05924-0","title":"ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer","year":2024,"lang":"en","type":"article","venue":"Communications Biology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Canadian Glycomics Network; National Institute of Diabetes and Digestive and Kidney Diseases; Biotechnology and Biological Sciences Research Council; Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Cancer Research UK; Academy of Medical Sciences; Newcastle University; Mark Foundation For Cancer Research; Prostate Cancer UK; Movember Foundation; Prostate Cancer Foundation; Alberta Innovates; JGW Patterson Foundation; Directorate for Biological Sciences","keywords":"Prostate cancer; Enzalutamide; Immune system; Cancer research; Immune checkpoint; Prostate; Cancer; Blockade; Immunology; Androgen receptor; Biology; Immunotherapy; Receptor; Medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008965252,0.0003225606,0.0007189478,0.000575078,0.0002815878,0.00002689694,0.001380041,0.0003695029,0.0005440405],"category_scores_gemma":[0.0002945384,0.0002794616,0.0002205339,0.000665581,0.001264054,0.0001782589,0.000296584,0.0008476634,0.0001406741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008661584,"about_ca_system_score_gemma":0.0003979761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00194461,"about_ca_topic_score_gemma":0.0005262143,"domain_scores_codex":[0.9969736,0.001248333,0.0008819068,0.0003543628,0.00003531187,0.0005065356],"domain_scores_gemma":[0.9952943,0.002874344,0.0001513344,0.001527194,0.0001282914,0.00002450406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002975299,0.0003492817,0.01345788,0.0000773432,0.0005153539,0.000003139541,0.001765979,0.000005583323,0.9568432,0.002370974,0.0002434487,0.02407028],"study_design_scores_gemma":[0.0008590251,0.0002224739,0.0294001,0.0004203508,0.0001419867,0.00003865466,0.0005487531,0.00003769194,0.9295189,0.0004520064,0.03797924,0.0003808115],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.78779,0.2069183,0.00003273723,0.003195423,0.0005358577,0.0004318654,0.0003774112,0.0001398226,0.0005785838],"genre_scores_gemma":[0.9389251,0.05980186,0.00008819676,0.00009440826,0.0000150619,0.0003753286,0.0003221382,0.00004042716,0.0003374349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1511351,"threshold_uncertainty_score":0.9999657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02188477063841132,"score_gpt":0.3022325264846977,"score_spread":0.2803477558462864,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}